Impact of screening programs on the prenatal diagnosis (detection rate) of trisomy 13 and 18 over a 30-year period
- 15 September 2026
- journal article
- research article
- Published by SAGE Publications in Journal of Medical Screening
Abstract
Objective: To evaluate the impact of screening policies in Tuscany on the detection of trisomy 13 and trisomy 18 (T13/T18) with respect to time of diagnosis. A secondary aim was to evaluate the prevalence of these aneuploidies and to report the associated malformations. Methods: Data were extracted from the population-based Registry of Congenital Anomalies of Tuscany. All confirmed cases of T13/T18 among live births, stillbirths, miscarriages and terminations of pregnancy were included over a 30-year period (1994–2023). The prevalence for both aneuploidies was calculated overall and by age group (<35 years old; ≥ 35 years old). For prenatally diagnosed cases, median gestational age at diagnosis was calculated. The frequencies of the most common associated abnormalities were also calculated. Results: About 529 fetuses were diagnosed with T13/T18, respectively 133 (25.1%) and 396 (74.9%). The prevalence among 10,000 births was 1.67 (95% CI 1.40–1.98) for T13 and 4.98 (95% CI 4.45–5.49) for T18. Prenatal detection rate for T13 increased from 88.2% (95% CI 72.5–96.7) to 100% (95% CI 88.1–100.0). For T18, it increased from 87.5% (95% CI 79.2–93.4) to 100% (95% CI 95.0–100.0). Median gestational age at discovery gradually decreased for both trisomies through the study period, from 17 to 12 weeks. The most common anomalies in T13 were nervous system anomalies (27.8%) and congenital heart defects (9.8%). T18-associated anomalies included congenital heart defects (11.9%) and nervous system anomalies (10.1%). Conclusion: The implementation of screening policies led to an improvement in the rate of detection of T13/18 and a decrease in the median gestational age at diagnosis.Keywords
This publication has 15 references indexed in Scilit:
- Changes in the Detection and Management of Foetal Trisomies over TimeGeburtshilfe und Frauenheilkunde, 2018
- A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases RegistrationEuropean Journal of Medical Genetics, 2018
- EUROCAT: an update on its functions and activitiesJournal of Community Genetics, 2018
- Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysisUltrasound in Obstetrics & Gynecology, 2017
- Accuracy of first‐trimester combined test in screening for trisomies 21, 18 and 13Ultrasound in Obstetrics & Gynecology, 2017
- Anatomy of trisomy 18Clinical Anatomy, 2016
- Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 2015
- Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004–2011American Journal of Medical Genetics Part A, 2013
- Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screeningEuropean Journal of Human Genetics, 2012
- Aneuploidy screening in the first trimesterAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2007